MYC and mantle cell lymphoma: In conclusion, our work suggested that assessment of cytoplasmic C-MYC overexpression, CD8 positive CTLs, and Ki-67 by immunohistochemical staining might be helpful for risk stratification and prognosis of MCL patients.